Printer Friendly

EPITOPE RECEIVES ADDITIONAL APPROVAL FOR EXPORT OF ORAL SPECIMEN COLLECTION DEVICE

 EPITOPE RECEIVES ADDITIONAL APPROVAL FOR EXPORT
 OF ORAL SPECIMEN COLLECTION DEVICE
 BEAVERTON, Ore., Sept. 21 /PRNewswire/ -- Epitope Inc. (AMEX: EPT) today announced that the U.S. Food and Drug Administration (FDA) has granted the company approval to export its OraSure(R) oral specimen collection device for use in HIV-1 testing in the countries of Mexico and Taiwan. Both countries had previously approved import of the OraSure device. The device is now approved for export to 15 countries and a Premarket Approval application for commercial distribution of OraSure in the United States is currently undergoing FDA review.
 Epitope Inc. is an Oregon corporation utilizing biotechnology to develop diagnostic tests for AIDS and other indications, therapeutic antimicrobial drugs and, through its agricultural unit, Agritope Inc., superior new plant varieties.
 -0- 9/21/92
 /CONTACT: Mary Hagen of Epitope, 503-641-6115; or Shari Annes of Annes Associates, 415-726-5400, for Epitope/
 (EPT) CO: Epitope Inc. ST: Oregon IN: MTC SU:


JH-LM -- SE012 -- 1898 09/21/92 17:38 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 21, 1992
Words:164
Previous Article:DWG CORPORATION REPORTS RESULTS
Next Article:EDUCATION ALTERNATIVES REPORTS FOURTH QUARTER AND YEAR END RESULTS
Topics:


Related Articles
EPITOPE'S ORASURE PREMARKET APPROVAL APPLICATION SCHEDULED FOR REVIEW BY FDA ADVISORY PANEL
EPITOPE ANNOUNCES GLOBAL MARKETING/MANUFACTURING PACTS AT SHAREHOLDERS' MEETING
EPITOPE FILES ADDITIONAL INFORMATION WITH FDA FOR ORASURE PREMARKET APPROVAL APPLICATION
EPITOPE REPORTS FIRST QUARTER OPERATING RESULTS
EPITOPE TO APPEAR AT FDA PANEL MEETING
EPITOPE RECEIVES FDA APPROVAL TO MARKET ORASURE DEVICE
EPITOPE REPORTS ORDERS FOR FIRST MILLION ORASURE DEVICES
EPITOPE ANNOUNCES COMPLETION OF DUE DILIGENCE PERIOD FOR AGREEMENT WITH SMITHKLINE BEECHAM
EPITOPE REPORTS SECOND QUARTER OPERATING RESULTS
Epitope Announces FDA Clearance of Oral Fluid Assay For Cannabanoids (Marijuana)

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters